Warning! GuruFocus detected
2 Severe warning signs
with MED.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Medifast Inc
NAICS : 812199
SIC : 7299
ISIN : US58470H1014
Share Class Description:
MED: Ordinary SharesDescription
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.07 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 1.04 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.94 | |||||
| Beneish M-Score | -3.07 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.8 | |||||
| 3-Year EBITDA Growth Rate | -57.8 | |||||
| 3-Year EPS without NRI Growth Rate | -49 | |||||
| 3-Year FCF Growth Rate | -32.8 | |||||
| 3-Year Book Growth Rate | 3.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 52.57 | |||||
| 9-Day RSI | 49.39 | |||||
| 14-Day RSI | 47.01 | |||||
| 3-1 Month Momentum % | -12.94 | |||||
| 6-1 Month Momentum % | -21.15 | |||||
| 12-1 Month Momentum % | -58.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.34 | |||||
| Quick Ratio | 2.68 | |||||
| Cash Ratio | 2.53 | |||||
| Days Inventory | 103.13 | |||||
| Days Payable | 71.97 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.9 | |||||
| Shareholder Yield % | 3.55 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 73.8 | |||||
| Operating Margin % | 0.48 | |||||
| Net Margin % | 0.35 | |||||
| FCF Margin % | 2.83 | |||||
| ROE % | 1.01 | |||||
| ROA % | 0.71 | |||||
| ROIC % | 1.96 | |||||
| 3-Year ROIIC % | 284.04 | |||||
| ROC (Joel Greenblatt) % | 5.03 | |||||
| ROCE % | 1.31 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 78.56 | |||||
| Forward PE Ratio | 46.95 | |||||
| PE Ratio without NRI | 128.55 | |||||
| Shiller PE Ratio | 2 | |||||
| PS Ratio | 0.26 | |||||
| PB Ratio | 0.74 | |||||
| Price-to-Tangible-Book | 0.74 | |||||
| Price-to-Free-Cash-Flow | 9.01 | |||||
| Price-to-Operating-Cash-Flow | 6.32 | |||||
| EV-to-EBIT | 3.65 | |||||
| EV-to-EBITDA | 0.67 | |||||
| EV-to-Revenue | 0.02 | |||||
| EV-to-FCF | 0.64 | |||||
| Price-to-GF-Value | 0.43 | |||||
| Price-to-Projected-FCF | 0.14 | |||||
| Price-to-Median-PS-Value | 0.16 | |||||
| Price-to-Graham-Number | 2.05 | |||||
| Price-to-Net-Current-Asset-Value | 1.1 | |||||
| Price-to-Net-Cash | 1.75 | |||||
| Earnings Yield (Greenblatt) % | 27.4 | |||||
| FCF Yield % | 11.01 | |||||
| Forward Rate of Return (Yacktman) % | 48.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:MED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medifast Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 602.463 | ||
| EPS (TTM) ($) | 0.18 | ||
| Beta | 0.49 | ||
| 3-Year Sharpe Ratio | -2.14 | ||
| 3-Year Sortino Ratio | -1.96 | ||
| Volatility % | 33.57 | ||
| 14-Day RSI | 47.01 | ||
| 14-Day ATR ($) | 0.612854 | ||
| 20-Day SMA ($) | 14.267 | ||
| 12-1 Month Momentum % | -58.67 | ||
| 52-Week Range ($) | 13.57 - 39.14 | ||
| Shares Outstanding (Mil) | 10.94 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medifast Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medifast Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medifast Inc Frequently Asked Questions
What is Medifast Inc(MED)'s stock price today?
The current price of MED is $14.14. The 52 week high of MED is $39.14 and 52 week low is $13.57.
When is next earnings date of Medifast Inc(MED)?
The next earnings date of Medifast Inc(MED) is 2025-04-29 Est..
Does Medifast Inc(MED) pay dividends? If so, how much?
Medifast Inc(MED) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers